Advances in translational therapy for locally advanced gastric cancer

World J Clin Cases. 2023 Apr 16;11(11):2405-2411. doi: 10.12998/wjcc.v11.i11.2405.

Abstract

Translational therapy refers to a combination of chemotherapy, radiotherapy, targeted therapy, and immunotherapy for patients with advanced gastric cancer who are initially unable to undergo R0 resection. This treatment can achieve partial or complete remission of the unresectable tumors to meet the criteria for R0 resection, thus enabling the patients to prolong their survival time and improve their quality of life. In gastric cancer, translational therapy has been tried and improved. At present, there are a large number of patients with locally advanced gastric cancer in China, and the selection of suitable patients for translational therapy to prolong objective survival and improve survival quality is one of the hot spots in the field of gastric cancer research.

Keywords: Chemotherapy; Gastric cancer; Locally advanced; Radiotherapy treatment; Targeted therapy; Translational therapy.

Publication types

  • Review